Monowar Hossain
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
PhD student
Also affiliated: The University of Texas at Austin (1976–1980)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Monowar Hossain's research investigates the development of nanomedicines for cancer therapy, focusing on near-infrared-responsive ionic nanoparticles. His work explores the use of macrocyclic histone deacetylase inhibitors as a component of these nanomedicines to enhance cancer treatment efficacy. Hossain has published work on carbon-based anode materials for metal-ion batteries and has historical publications in particle physics. His recent work aligns with advancements in nanomedicine and cancer treatment, with a publication in 2026 detailing near-infrared-responsive ionic nanomedicines for enhanced cancer therapy. Hossain collaborates with researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Sayyed Hussain, Fatima Hashim Abbas, and Adeniyi Oyebade.
Metrics
- h-index: 3
- Publications: 9
- Citations: 25
Positions
-
PhD student 2025–presentUniversity of Arkansas at Little Rock Chemistry ORCID
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
-
Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions (2025)
Collaboration Network
Top Collaborators
- Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Carbon-Based Anode Materials for Metal-Ion Batteries: Current Status, Challenges, and Future Directions
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
Similar Researchers
Based on overlapping research topics